Urea-containing peptide boronic acids as potent proteasome inhibitors

Abstract

A novel class of urea-containing peptide boronic acids as proteasome inhibitors was designed by introducing a urea scaffold to replace an amido bond. Compounds were synthesized and their antitumor activities were evaluated. After two rounds of optimizations, the compound I-14 was found to be a potent proteasome inhibitor. Compared with Bortezomib, I-14 showed higher potency against the chymotrypsin-like activity of human 20S proteasome (IC₅₀ < 1 pM), similar potency against four different cancer cell lines (IC₅₀ < 10 nM), and better pharmacokinetic profile. Furthermore, I-14 significantly inhibited tumor growth in Bel7404 mouse xenograft model. The excellent proteasome inhibition by I-14 was rationalized through docking and molecular dynamics studies.

Keywords: Anti-tumor activity; Low toxicity; Proteasome inhibitor; Structure-activity relationship; Urea-containing peptide boronic acids.